Is age just a number? Oncotype DX testing and chemotherapy use in the post‐TAILORx era
In the post-TAILORx era, younger age was associated with substantially more ODX testing. The association of testing with chemotherapy varied substantially by age. The impact of age on ODX testing and use of chemotherapy is substantial and warrants further study.
Authors
- Shiyun Zhu
- Raymond Liu (ORCID: https://orcid.org/0000-0002-4667-9632)
- Laurel A. Habel (ORCID: https://orcid.org/0000-0002-7230-587X)
- Scott D. Casey (ORCID: https://orcid.org/0000-0001-6733-2155)
- Ashley Aller (ORCID: https://orcid.org/0000-0002-9681-8581)
- Aida Shirazi (ORCID: https://orcid.org/0000-0002-6615-2125)
- Liisa Lyon
Institutions
- Kaiser Permanente (US)
- Kaiser Permanente Vallejo Medical Center (US)
- Kaiser Permanente San Francisco Medical Center (US)
- Northwest Medical Specialties (US)
Publication Details
- Journal
- Cancer
- Published
- 2025-12-12
- DOI
- https://doi.org/10.1002/cncr.70218
- Primary Topic
- Economic and Financial Impacts of Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00